argenx at Antibody Engineering 2026

Dec 13–16, 2026 San Diego, CA ~900 attendees Website

argenx takes part in 1 session at Antibody Engineering 2026 in San Diego. Its program centers on an engineered antibody approach that lowers levels of every IgG subclass. The work points to uses outside cancer, in line with argenx's focus on autoimmune disease.

OrganizationAntibody Engineering 2026 Attendance
Biotech
Immunology company developing antibody-based medicines for autoimmune diseases, with marketed FcRn-blocking therapy.
Talk
Wed Dec 16
4:45pm–5:15pm
A Novel Antibody Approach to Pan-subclass IgG Reduction
An antibody that sweeps up and destroys every subtype of the main antibody class in blood, for diseases caused by self-attacking antibodies.
Beyond oncology

Explore the full Antibody Engineering 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Diego. Leave your work email and we’ll be in touch.

Privacy

Download the full Antibody Engineering 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at argenx

Tell us what you sell and we’ll find the people at argenx most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by Antibody Engineering & Therapeutics, its organizers or The Antibody Society. Submit a correction